Nishii Y - Search Results

1

22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.

Farach-Carson MC, Abe J, Nishii Y, Khoury R, Wright GC, Norman AW. Farach-Carson MC, et al. Among authors: nishii y. Am J Physiol. 1993 Nov;265(5 Pt 2):F705-11. doi: 10.1152/ajprenal.1993.265.5.F705. Am J Physiol. 1993. PMID: 8238551

2

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.

Nishii Y, Abe J, Mori T, Brown AJ, Dusso AS, Finch J, Lopez-Hilker S, Morrissey J, Slatopolsky E. Nishii Y, et al. Contrib Nephrol. 1991;91:123-8. doi: 10.1159/000420167. Contrib Nephrol. 1991. PMID: 1800003 Review.

3

Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.

Abe J, Kondo S, Nishii Y, Kuroki T. Abe J, et al. Among authors: nishii y. J Clin Endocrinol Metab. 1989 Apr;68(4):851-4. doi: 10.1210/jcem-68-4-851. J Clin Endocrinol Metab. 1989. PMID: 2921314

4

A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.

Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E, Ikeda K. Abe J, et al. Among authors: nishii y. Endocrinology. 1991 Aug;129(2):832-7. doi: 10.1210/endo-129-2-832. Endocrinology. 1991. PMID: 1855478

5

Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3.

Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y. Abe J, et al. Among authors: nishii y. J Nutr Sci Vitaminol (Tokyo). 1990 Feb;36(1):21-31. doi: 10.3177/jnsv.36.21. J Nutr Sci Vitaminol (Tokyo). 1990. PMID: 2163440

6

A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.

Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y. Abe J, et al. Among authors: nishii y. Endocrinology. 1989 May;124(5):2645-7. doi: 10.1210/endo-124-5-2645. Endocrinology. 1989. PMID: 2539984

7

Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.

Abe J, Moriya Y, Saito M, Sugawara Y, Suda T, Nishii Y. Abe J, et al. Among authors: nishii y. Cancer Res. 1986 Dec;46(12 Pt 1):6316-21. Cancer Res. 1986. PMID: 3490908

8

Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia.

Abe J, Morikawa M, Miyamoto K, Kaiho S, Fukushima M, Miyaura C, Abe E, Suda T, Nishii Y. Abe J, et al. Among authors: nishii y. FEBS Lett. 1987 Dec 21;226(1):58-62. doi: 10.1016/0014-5793(87)80550-1. FEBS Lett. 1987. PMID: 2826255 Free article.

9

Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.

Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E. Finch JL, et al. Among authors: nishii y. J Bone Miner Res. 1992 Jul;7(7):835-9. doi: 10.1002/jbmr.5650070713. J Bone Miner Res. 1992. PMID: 1642151

10

Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism.

Finch JL, Brown AJ, Kubodera N, Nishii Y, Slatopolsky E. Finch JL, et al. Among authors: nishii y. Kidney Int. 1993 Mar;43(3):561-6. doi: 10.1038/ki.1993.83. Kidney Int. 1993. PMID: 8455354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters